Aug 27 |
Eli Lilly releases new form of Zepbound in bid to lower price
|
Aug 27 |
Why Hims & Hers Health Stock Is Falling
|
Aug 27 |
Eli Lilly stock dips as single-dose Zepbound price is cut in half
|
Aug 27 |
Shortages improve for Lilly’s GLP-1 weight loss drugs, bumping sales forecast by $3bn
|
Aug 27 |
Eli Lilly slashes Zepbound prices for self-pay patients
|
Aug 27 |
Eli Lilly Launches Cheaper Single-Use Vials of Weight-Loss Drug Zepbound
|
Aug 27 |
Eli Lilly's Stock Keeps Looking Better and Better. Here's the Latest Reason Why.
|
Aug 27 |
Merck Stock Worth Watching on PAH Drug Winrevair's Approval in Europe?
|
Aug 27 |
Eli Lilly Halves Zepbound Price In New Version Of Weight-Loss Drug
|
Aug 27 |
Eli Lilly Offers a Cheaper Form of Zepbound. Why Hims & Hers Stock Is Falling.
|